Demographic data
|
Age
|
|
|
Sex
|
|
|
Height
|
|
|
Weight
|
|
|
Smoking status
|
|
Chronic diseases
|
Diabetes mellitus type 2
|
± micro- or macro-vascular complications
|
|
Arterial hypertension
|
|
|
Atrial fibrillation
|
|
|
Heart failure
|
(including NYHA-stage)
|
|
Cardiovascular diseases
|
Myocardial infarction, aortocoronary bypass or stenting, angina pectoris and coronary stenosis* , peripheral arterial occlusive disease, peripheral arterial thromboembolism
|
|
Cerebrovascular diseases
|
Stroke, transitory ischemic attack, carotid endarterectomy or stenting
|
Medication
|
Oral antidiabetics
|
Metformin
|
|
Antihypertensive drugs
|
Inhibitors of the renin-angiotensin-aldosterone system (RAAS), diuretics (thiazides, furosemide) calcium channel blockers, beta-blockers
|
|
Platelet aggregation Inhibitors
|
Acetylsalicylic acid, clopidogrel, prasugrel
|
|
Anticoagulants
|
Vitamine-K-antagonists
|
|
Lipid lowering therapy
|
Statins
|
Medical data (via patient’s health records)
|
Blood pressure
|
Singular measurement, multiple self-measurements or 24-h record if available
|
|
HbA1c
|
|
|
Creatinine level
|
|
|
International normalized ratio
|
In case of oral anticoagulation
|
|
Total serum cholesterol, LDL and HDL levels |
|